source
- FDA and CMS work to prevent regulatory clash as states move to test clinical AIOfficials at the FDA and CMS are working behind the scenes to avoid a regulatory clash as more states plan to test artificial intelligence tools that perform clinical tasks. The tension arises fro…
- Setara Biosciences raises $90 million to advance rare-disease pipeline after Actio spin-outActio Biosciences shipped its precision epilepsy drug to Jazz Pharmaceuticals and then separated the rest of its genetics-driven pipeline into a new company called Setara Biosciences. Setara has s…